Cargando…
Nitroglycerin Use in the Emergency Department: Current Perspectives
Nitroglycerin, a fast-acting vasodilator, is commonly used as a first-line agent for angina in the emergency department and to manage chest pain due to acute coronary syndromes. It is also a treatment option for other disease states such as acute heart failure, pulmonary edema, and aortic dissection...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278720/ https://www.ncbi.nlm.nih.gov/pubmed/35847764 http://dx.doi.org/10.2147/OAEM.S340513 |
_version_ | 1784746244277534720 |
---|---|
author | Twiner, Michael J Hennessy, John Wein, Rachel Levy, Phillip D |
author_facet | Twiner, Michael J Hennessy, John Wein, Rachel Levy, Phillip D |
author_sort | Twiner, Michael J |
collection | PubMed |
description | Nitroglycerin, a fast-acting vasodilator, is commonly used as a first-line agent for angina in the emergency department and to manage chest pain due to acute coronary syndromes. It is also a treatment option for other disease states such as acute heart failure, pulmonary edema, and aortic dissection. Nitroglycerin is converted to nitric oxide, a potent vasodilator, in the body, leading to venodilation at lower dosages and arteriodilation at higher dosages that results in both preload and afterload reduction, respectively. Although nitroglycerin has historically been administered as a sublingual tablet and/or spray, it is often given intravenously in the emergency department as this enables titration to effect with predictable pharmacokinetics. In this review article, we outline the indications, mechanism of action, contraindications, and adverse effects of nitroglycerin as well as review relevant literature and make general recommendations regarding the use of nitroglycerin in the emergency department. |
format | Online Article Text |
id | pubmed-9278720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92787202022-07-14 Nitroglycerin Use in the Emergency Department: Current Perspectives Twiner, Michael J Hennessy, John Wein, Rachel Levy, Phillip D Open Access Emerg Med Review Nitroglycerin, a fast-acting vasodilator, is commonly used as a first-line agent for angina in the emergency department and to manage chest pain due to acute coronary syndromes. It is also a treatment option for other disease states such as acute heart failure, pulmonary edema, and aortic dissection. Nitroglycerin is converted to nitric oxide, a potent vasodilator, in the body, leading to venodilation at lower dosages and arteriodilation at higher dosages that results in both preload and afterload reduction, respectively. Although nitroglycerin has historically been administered as a sublingual tablet and/or spray, it is often given intravenously in the emergency department as this enables titration to effect with predictable pharmacokinetics. In this review article, we outline the indications, mechanism of action, contraindications, and adverse effects of nitroglycerin as well as review relevant literature and make general recommendations regarding the use of nitroglycerin in the emergency department. Dove 2022-07-09 /pmc/articles/PMC9278720/ /pubmed/35847764 http://dx.doi.org/10.2147/OAEM.S340513 Text en © 2022 Twiner et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Twiner, Michael J Hennessy, John Wein, Rachel Levy, Phillip D Nitroglycerin Use in the Emergency Department: Current Perspectives |
title | Nitroglycerin Use in the Emergency Department: Current Perspectives |
title_full | Nitroglycerin Use in the Emergency Department: Current Perspectives |
title_fullStr | Nitroglycerin Use in the Emergency Department: Current Perspectives |
title_full_unstemmed | Nitroglycerin Use in the Emergency Department: Current Perspectives |
title_short | Nitroglycerin Use in the Emergency Department: Current Perspectives |
title_sort | nitroglycerin use in the emergency department: current perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278720/ https://www.ncbi.nlm.nih.gov/pubmed/35847764 http://dx.doi.org/10.2147/OAEM.S340513 |
work_keys_str_mv | AT twinermichaelj nitroglycerinuseintheemergencydepartmentcurrentperspectives AT hennessyjohn nitroglycerinuseintheemergencydepartmentcurrentperspectives AT weinrachel nitroglycerinuseintheemergencydepartmentcurrentperspectives AT levyphillipd nitroglycerinuseintheemergencydepartmentcurrentperspectives |